Approval · Notice of Compliance 29286 · 2022
PREZCOBIX: Notice of Compliance 29286
Issued October 20, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29286
- Date
- October 20, 2022
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Removal of the class warning related to lipodystrophy from the Product Monograph (PM) and updates related to drug-drug interactions.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PREZCOBIX | Not yet assigned | — |
Medicinal ingredients
- DARUNAVIR ETHANOLATE 800 MG per TAB
- COBICISTAT 150 MG per TAB